Masoumeh Simbar

Prof. Masoumeh Simbar

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
MSMasoumeh Simbar
Masoumeh Simbar
MTMaryam Tohidi
Maryam Tohidi
FHFarhad Hosseinpanah
Farhad Hosseinpanah
FAFereidoun Azizi
Fereidoun Azizi
Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (NIH), the Rotterdam consensus (Rott.) and the Androgen Excess Society (AES) criteria. Using the stratified, multistage probability cluster sampling method, 1126 women were randomly selected from among reproductive aged women of different geographic regions of Iran. PCOS were diagnosed using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. The mean +/- SD of age of study population was 34.4 +/- 7.6 years. Estimated prevalence of idiopathic hirsutism was 10.9% (95% CI: 8.9-12.9%); 8.3% of women had only oligo/anovulation and 8.0% had only polycystic ovaries. The prevalence of PCOS was 7.1% (95% CI: 5.4-8.8%) using the NIH definition, 11.7% (95% CI: 9.5-13.7%) by AES criteria and 14.6% (95% CI: 12.3-16.9%) using the Rott definition. At community level, widespread screening of Rotterdam criteria will increase the estimated prevalence of PCOS over twofold. Establishing an explicit and contemporaneous method for definition and screening of each PCOS criteria has important investigational implications and increase the comparability of published research.

1 February 2017 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
SNSima Nazarpour
Sima Nazarpour
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
MSMasoumeh Simbar
Masoumeh Simbar
MTMaryam Tohidi
Maryam Tohidi
HAHamid Alavimajd
Hamid Alavimajd
FAFereidoun Azizi
Fereidoun Azizi
Background: Despite some studies indicating that thyroid antibody positivity during pregnancy has been associated with adverse pregnancy outcomes, evidence regarding the effects of levothyroxine (LT4) treatment of euthyroid/subclinical hypothyroid pregnant women with autoimmune thyroid disease on pregnancy outcome is limited. We aimed to assess whether pregnant women with autoimmune thyroid disease, but without overt thyroid dysfunction are affected by higher rates of adverse pregnancy outcomes. In addition, we aimed to explore whether LT4 treatment improves the pregnancy outcome of affected women. Methods: A prospective study was carried out on pregnant women from the first trimester to delivery. The study was conducted among pregnant women receiving prenatal care in centers under coverage of Shahid Beheshti University of Medical Sciences. Of a total of 1746 pregnant women, screened for thyroid dysfunction, 1028 euthyroid TPOAb-negative (TPOAb−) and 131 thyroid peroxidase antibody-positive (TPOAb+) women without overt thyroid dysfunction entered the second phase of the study. TPOAb+ women were randomly divided into two groups: group A (n = 65), treated with LT4 and group B (n = 66), received no treatment. The 1028 TPOAb− women (group C) served as a normal population control group. Primary outcomes were preterm delivery and miscarriage and secondary outcomes included placenta abruption, still birth, neonatal admission and neonatal TSH levels. Results: Groups A and C displayed a lower rate of preterm deliveries compared with group B (RR = 0.30, 95% CI: 0.1–0.85, P = 0.0229) and (RR = 0.23, 95% CI: 0.14–0.40, P < 0.001) respectively. There was no statistically significant difference in the rates of preterm labor between groups A and C (RR = 0.79, 95% CI: 0.30–2.09, P = 0.64). The number needed to treat (NNT) for preterm birth was 5.9 (95% CI: 3.33–25.16) Conclusions: Treatment with LT4 decreases the risk of preterm delivery in women who are positive for TPOAb.

4 March 2021 in Fertility Research and Practice
Verified
Journal Article
Open access
PDF file
ZKZahra Kiani
Zahra Kiani
MSMasoumeh Simbar
Masoumeh Simbar
SHSepideh Hajian
Sepideh Hajian
FZFarid Zayeri
Farid Zayeri
Background: Infertile women’s mental health problems, including depression, are key fertility health issues that affect infertile women more severely than infertile men. Depression may threaten the health of individuals and reduce the quality of their lives. Considering the role and impact of depression on responses to infertility treatments, a systematic review and meta-analysis were conducted to investigate the prevalence of depression symptoms among infertile women. Methods: International databases (PubMed, Cochrane Library, Web of Sciences, Scopus, Embase, and PsycINFO), national databases (SID and Magiran), and Google Scholar were searched by two independent reviewers for articles published from 2000 to April 5, 2020. The search procedure was performed in both Persian and English using keywords such as “depression,” “disorders,” “infertility,” “prevalence,” and “epidemiology.” The articles were evaluated in terms of their titles, abstracts, and full texts. The reviewers evaluated the quality of the articles using the Newcastle–Ottawa Scale, after which they analyzed the findings using STATA version 14. The I2 and Egger’s tests were performed to examine heterogeneity and publication bias, respectively. Results: Thirty-two articles were subjected to the meta-analysis, and a random effects model was used in the examination given the heterogeneity of the articles. The samples in the reviewed studies encompassed a total of 9679 infertile women. The lowest and highest pooled prevalence rates were 21.01% (95% confidence interval [CI]: 15.61–34.42), as determined using the Hospital Anxiety and Depression Scale, and 52.21% (95% CI: 43.51–60.91), as ascertained using the Beck Depression Inventory, respectively. The pooled prevalence values of depression among infertile women were 44.32% (95% CI: 35.65–52.99) in low- and middle-income countries and 28.03% (95% CI: 19.61–36.44) in high-income countries. Conclusion: The prevalence of depression among infertile women was higher than that among the general population of a given country. Especially in low- and middle-income countries, appropriate measures, planning, and policy that target the negative effects of depression on infertile women’s lives should be established to reduce related problems.

1 March 2009 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
GOGiti Ozgoli
Giti Ozgoli
MGMarjan Goli
Marjan Goli
MSMasoumeh Simbar
Masoumeh Simbar
Objective: The aim of this study was to determine the effects of ginger in nausea and vomiting of pregnancy. Design: This was a single blind clinical trial study, Setting: The study was conducted in a selected prenatal care clinic of Isfahan City hospitals Subjects: The subjects included 67 pregnant women who complained of nausea and vomiting from Isfahan city hospitals participated in the study. Intervention: The participants were randomly assigned to two groups, an experimental group and a control group. The groups were matched according to the age, gestational age, parity, occupational status, and educational level of the participants. The experimental group received ginger 250 mg capsules for 4 days, and the control group received placebo with the same prescription form. Outcome measures: Effects of treatment of nausea were evaluated twice daily for 4 days by a before-and-after treatment questionnaire. Results: The mean ages of the experimental and control groups were 24.1 ± 4.8 and 23.3 ± 5 years, respectively. The mean gestational age was 13 ± 3 weeks, and the mean parity was 1.6 ± 0.8. The ginger users demonstrated a higher rate of improvement than the placebo users did (85% versus 56%; p < 0.01). The decrease in vomiting times among ginger users was also significantly greater than among the women who received the placebo (50% versus 9%; p < 0.05). Discussion: A daily total of 1000 mg of ginger in a capsule preparation can be suggested by care providers as a means of decreasing pregnancy nausea and vomiting in women who tend to herbal medicines. Conclusion: Ginger is an effective herbal remedy for decreasing nausea and vomiting during pregnancy.

1 August 2016 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
SNSoheila Nazarpour
Soheila Nazarpour
MSMasoumeh Simbar
Masoumeh Simbar
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
This study aimed to systematically review the articles on factors affecting sexual function during menopause. Searching articles indexed in Pubmed, Science Direct, Iranmedex, EMBASE, Scopus, and Scientific Information Database databases, a total number of 42 studies published between 2003 and 2013 were selected. Age, estrogen deficiency, type of menopause, chronic medical problems, partner's sex problems, severity of menopause symptoms, dystocia history, and health status were the physical factors influencing sexual function of menopausal women. There were conflicting results regarding the amount of androgens, hormonal therapy, exercise/physical activity, and obstetric history. In the mental-emotional area, all studies confirmed the impact of depression and anxiety. Social factors, including smoking, alcohol consumption, the quality of relationship with husband, partner's loyalty, sexual knowledge, access to health care, a history of divorce or the death of a husband, living apart from a spouse, and a negative understanding of women's health were found to affect sexual function; however, there were conflicting results regarding the effects of education, occupation, socioeconomic status, marital duration, and frequency of sexual intercourse.

1 March 2018 in Journal of Integrative Medicine
Verified
Journal Article
Closed access
SHSepideh Hamdamian
Sepideh Hamdamian
SNSima Nazarpour
Sima Nazarpour
MSMasoumeh Simbar
Masoumeh Simbar
SHSepideh Hajian
Sepideh Hajian
FMFaraz Mojab
Faraz Mojab
ATAtefeh Talebi
Atefeh Talebi